Benad Goldwasser

Zeev Vurembrand to Join ScoutCam's Board of Directors

Retrieved on: 
Wednesday, May 19, 2021
Health maintenance organizations, Clalit Health Services, Kupat Holim Meuhedet, Benad Goldwasser, Organizations, Technion – Israel Institute of Technology, Health, Economy

b'OMER, Israel, May 19, 2021 (GLOBE NEWSWIRE) -- ScoutCam (OTCQB:SCTC), a leading developer and manufacturer of customized micro visual solutions and supplementary technologies, today announced that Mr. Zeev Vurembrand has been appointed to its board of directors.

Key Points: 
  • b'OMER, Israel, May 19, 2021 (GLOBE NEWSWIRE) -- ScoutCam (OTCQB:SCTC), a leading developer and manufacturer of customized micro visual solutions and supplementary technologies, today announced that Mr. Zeev Vurembrand has been appointed to its board of directors.
  • Mr. Vurembrand was previously the Chief Executive Officer of Clalit Health Services Group and Kupat Holim Meuhedet, Israel\xe2\x80\x99s largest and third largest health care organizations, respectively, Alon Holding Blue Square, and Phoenix Investments.
  • Vurembrand is a graduate of Technion, Israeli Institute of Technology, where he earned a degree in industrial engineering and management.\n\xe2\x80\x9cWe are very pleased to add the support of Mr. Vurembrand to our Board of Directors", said Prof. Benad Goldwasser, the Executive Chairman of the Board.
  • Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.\n'

Inspira Technologies Appoints Benad Goldwasser as Chairman of the Board

Retrieved on: 
Wednesday, February 24, 2021
Benad Goldwasser, Investors, Goldwasser, Urology, German culture

RA'ANANA, Israel, Feb. 24, 2021 /PRNewswire/ -- Inspira Technologies Ltd ., a leader in respiratory medical technology, announced today that it has appointed Professor Benad Goldwasser as Chairman of the Board of Directors.

Key Points: 
  • RA'ANANA, Israel, Feb. 24, 2021 /PRNewswire/ -- Inspira Technologies Ltd ., a leader in respiratory medical technology, announced today that it has appointed Professor Benad Goldwasser as Chairman of the Board of Directors.
  • As Chairman of the Board, Prof. Goldwasser will leverage his expertise in leading high growth, publicly traded companies to help drive the long-term development of Inspira Technologies' medical device portfolio.
  • Following his career as a urologic surgeon, Prof. Goldwasser became a prolific entrepreneur and business executive in the healthcare industry.
  • "We look forward to working with Prof. Goldwasser as Chairman of the Board as he lends his experience and insights to the further growth of the company.

Medigus: Leading Life Science and Pharmaceutical Entrepreneur Mori Arkin to Join ScoutCam’s Board of Directors

Retrieved on: 
Tuesday, February 16, 2021
Pharmaceutical companies, Mori Arkin, Perrigo, Benad Goldwasser, Mori, Arkin, Companies

On May 18, 2020, Mr. Arkin invested $2 million in ScoutCam through his investment company, Arkin Holdings, and, in connection with the investment, appointed Dr. Irit Yaniv as a ScoutCams board member and representative of Arkin Holdings.

Key Points: 
  • On May 18, 2020, Mr. Arkin invested $2 million in ScoutCam through his investment company, Arkin Holdings, and, in connection with the investment, appointed Dr. Irit Yaniv as a ScoutCams board member and representative of Arkin Holdings.
  • Prof. Benad Goldwasser, the Executive Chairman of Scoutcams board, expressed his gratitude to Dr. Yaniv for her contribution.
  • Founder and Chairman of Arkin Holdings, Moshe Mori Arkin, is one of Israels most successful life sciences and pharmaceutical entrepreneurs.
  • Mori previously grew Agis into a leading pharmaceutical company and sold it to Perrigo in 2005 for $818 million.

Medigus and Intellisense Close Merger

Retrieved on: 
Thursday, January 2, 2020
Stock market, Finance, Money, Equity securities, Economy, Corporate finance, Benad Goldwasser, Investors, Share, Stock, Security

Medigus previously announced the signing of the securities exchange agreement on September 17, 2019.

Key Points: 
  • Medigus previously announced the signing of the securities exchange agreement on September 17, 2019.
  • The aggregate value of the shares issued to Medigus in the post-closing company is approximately $8 million.
  • The closing of this transaction signifies an important milestone for both Medigus and ScoutCam, said Professor Benad Goldwasser, outgoing chairman of the Medigus board of directors.
  • We look forward to ScoutCams continued growth following this latest influx of funding, and, as a 60% stockholder, Medigus will to enjoy the return.